These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25294622)

  • 21. Exposure to Marijuana Marketing After Legalization of Retail Sales: Oregonians' Experiences, 2015-2016.
    Fiala SC; Dilley JA; Firth CL; Maher JE
    Am J Public Health; 2018 Jan; 108(1):120-127. PubMed ID: 29161062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bayesian inference for the distribution of grams of marijuana in a joint.
    Ridgeway G; Kilmer B
    Drug Alcohol Depend; 2016 Aug; 165():175-80. PubMed ID: 27346327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deglamorising cannabis.
    Lancet; 1995 Nov; 346(8985):1241. PubMed ID: 7475708
    [No Abstract]   [Full Text] [Related]  

  • 24. Assessing the harms of cannabis cultivation in Belgium.
    Paoli L; Decorte T; Kersten L
    Int J Drug Policy; 2015 Mar; 26(3):277-89. PubMed ID: 25599596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Field observations of the developing legal recreational cannabis economy in Washington State.
    Jensen EL; Roussell A
    Int J Drug Policy; 2016 Jul; 33():96-101. PubMed ID: 27296756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimating the economic value of British Columbia's domestic cannabis market: implications for provincial cannabis policy.
    Werb D; Nosyk B; Kerr T; Fischer B; Montaner J; Wood E
    Int J Drug Policy; 2012 Nov; 23(6):436-41. PubMed ID: 23085258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production, perceptions, and punishment: restrictive deterrence in the context of cannabis cultivation.
    Nguyen H; Malm A; Bouchard M
    Int J Drug Policy; 2015 Mar; 26(3):267-76. PubMed ID: 25223245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uneven effects of twenty years of Chile's cannabis policy implementation in cannabis onset.
    Nazif-Munoz JI; Domínguez-Cancino K; Martínez P; Jauffret-Roustide M
    Int J Drug Policy; 2024 May; 127():104395. PubMed ID: 38531189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabis and progression to other substance use in young adults: findings from a 13-year prospective population-based study.
    Swift W; Coffey C; Degenhardt L; Carlin JB; Romaniuk H; Patton GC
    J Epidemiol Community Health; 2012 Jul; 66(7):e26. PubMed ID: 21771817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabis clubs in Uruguay: The challenges of regulation.
    Queirolo R; Boidi MF; Cruz JM
    Int J Drug Policy; 2016 Aug; 34():41-8. PubMed ID: 27475713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Colorado, the lost battle of public health].
    Deleuze J
    Rev Prat; 2014 Feb; 64(2):151. PubMed ID: 24701864
    [No Abstract]   [Full Text] [Related]  

  • 32. Medicinal marijuana. An overview of California's Proposition 215.
    McNamara P
    Adv NPs PAs; 2011 Jan; 2(1):45-7. PubMed ID: 21329234
    [No Abstract]   [Full Text] [Related]  

  • 33. Early childhood predictors of age of initiation to use of cannabis: a birth prospective study.
    Hayatbakhsh R; Williams GM; Bor W; Najman JM
    Drug Alcohol Rev; 2013 May; 32(3):232-40. PubMed ID: 23061516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimating the production, consumption and export of cannabis: The Dutch case.
    van der Giessen M; van Ooyen-Houben MM; Moolenaar DE
    Int J Drug Policy; 2016 May; 31():104-12. PubMed ID: 27048853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing the public health impacts of legalizing recreational cannabis use in the USA.
    Hall W; Weier M
    Clin Pharmacol Ther; 2015 Jun; 97(6):607-15. PubMed ID: 25777798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabis prices and dynamics of cannabis use.
    van Ours JC; Williams J
    J Health Econ; 2007 May; 26(3):578-96. PubMed ID: 17097174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potency increase, product development and marijuana marketing in times of legalization.
    Carlini BH
    Addiction; 2017 Dec; 112(12):2178-2179. PubMed ID: 29105921
    [No Abstract]   [Full Text] [Related]  

  • 38. Attitudes to legalizing cannabis use.
    Williams J; van Ours JC; Grossman M
    Health Econ; 2016 Sep; 25(9):1201-16. PubMed ID: 27037958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabis consumption patterns among frequent consumers in Uruguay.
    Boidi MF; Queirolo R; Cruz JM
    Int J Drug Policy; 2016 Aug; 34():34-40. PubMed ID: 27397717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The development and pilot testing of the marijuana retail surveillance tool (MRST): assessing marketing and point-of-sale practices among recreational marijuana retailers.
    Berg CJ; Henriksen L; Cavazos-Rehg P; Schauer GL; Freisthler B
    Health Educ Res; 2017 Dec; 32(6):465-472. PubMed ID: 29237032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.